67
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen

, , , , , , , , , , , , , , , , , & show all
Pages 259-268 | Published online: 06 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hannah Ewald, Marilia Santini-Oliveira, Julian-Emanuel Bühler, Danielle Vuichard, Stefan Schandelmaier, Marcel Stöckle, Matthias Briel, Heiner C. Bucher & Lars G. Hemkens. (2017) Comparative effectiveness of tenofovir in HIV-infected treatment-experienced patients: systematic review and meta-analysis. HIV Clinical Trials 18:1, pages 17-27.
Read now
Curtis Cooper, Charles la Porte, Harout Tossonian, John Sampalis, Nabil Ackad & Brian Conway. (2012) A Pilot, Prospective, Open-Label Simplification Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Once-Daily Lopinavir-Ritonavir Monotherapy in HIV-HCV Coinfected Patients: The MONOCO Study. HIV Clinical Trials 13:4, pages 179-188.
Read now

Articles from other publishers (1)

Linda Wittkop, Colette Smith, Zoe Fox, Caroline Sabin, Laura Richert, Jean-Pierre Aboulker, Andrew Phillips, Genevieve Chêne, Abdel Babiker & Rodolphe Thiébaut. (2010) Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field. Clinical Trials 7:1, pages 19-35.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.